Related Experiment Video
Updated: May 10, 2026
07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Metformin, microbes, and aging
Gilles Storelli1, Mélisandre Téfit1, François Leulier1
1Institut de Génomique Fonctionnelle de Lyon (IGFL), Ecole Normale Supérieure de Lyon, CNRS UMR 5242, Université Claude Bernard Lyon-1, 46 Allée d'Italie, 69364 Lyon Cedex 07, France.
Cell Metabolism
|June 11, 2013
Summary
Metformin, a diabetes drug, extends lifespan in C. elegans by altering the methionine metabolism of its gut bacteria, E. coli. This study reveals an indirect mechanism for metformin
Area of Science:
- Microbiology
- Gerontology
- Pharmacology
Background:
- Metformin is a first-line medication for type 2 diabetes.
- The precise biological mechanisms of metformin's action are not fully understood.
- Metformin's effects may extend beyond glycemic control, potentially influencing aging.
Purpose of the Study:
- To investigate the underlying mechanisms of metformin's biological activity.
- To explore the impact of metformin on lifespan in a model organism.
- To determine if metformin's effects are mediated by its interaction with microbial communities.
Main Methods:
- Utilized the nematode C. elegans as a model organism.
- Administered metformin to C. elegans populations.
- Analyzed changes in methionine metabolism within the gut bacterium E. coli.
- Assessed the impact of these metabolic alterations on C. elegans lifespan.
Main Results:
- Metformin treatment led to significant alterations in methionine metabolism in E. coli.
- These metabolic changes in E. coli were found to indirectly influence the lifespan of C. elegans.
- The study identified a novel indirect mechanism for metformin's biological effects.
Conclusions:
- Metformin's beneficial effects on lifespan in C. elegans are mediated through its interaction with the gut microbiome.
- Altering microbial metabolism, specifically methionine metabolism in E. coli, is a key mechanism for metformin's impact on aging.
- This research highlights the importance of the host-microbiome interaction in drug efficacy and aging processes.
Related Concept Videos
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:30Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...